Blog
Discover our latest articles and blogs
RBQM Platforms: What They Do and How to Choose One
What an RBQM platform does, which capabilities matter, how FDA and ICH E6(R3) frame risk-based quality, and how biotech sponsors can pick and prove one.
CDISC Mapping Automation: A Practical Guide for Biotech
How to automate CDISC SDTM mapping: the metadata you need, rule-based versus AI-assisted methods, validation for FDA submissions, and where automation fails.
Biotech Bottleneck Analysis: Find What Slows Your Timeline
A practical guide to biotech bottleneck analysis: map your process, find the rate-limiting step, prioritize fixes and measure the time you win back.
CTA Negotiation Automation: A Practical Guide for Biotech
How to automate clinical trial agreement negotiation: where CTAs stall, what to standardize first, where AI helps, where people decide, and how to measure it.
GxP Document Classification: A Practical Guide for U.S. Teams
How to classify GxP documents and records by regulatory impact and risk, assign controls to each class, and avoid the gaps FDA inspectors look for in the U.S.
MedDRA Coding Automation: What Works and What Breaks
How to automate MedDRA coding without losing accuracy: where AI helps, where humans must stay, and how to govern synonym lists, versions and review.
AI Center of Excellence in Pharma: Build One That Ships
How to build an AI center of excellence in pharma that moves past pilots: operating model, governance, FDA expectations, staffing and when to bring in a partner.
BLA Submission Automation: What to Automate and What Not
Where automation speeds up a BLA submission, from eCTD publishing to drafting, and where FDA expects humans and validation. A practical guide for US sponsors.
Executive Alignment Workshop: A Guide for Biotech Leaders
How to design an executive alignment workshop for a biotech leadership team: agenda, pre-work, decision rights, and follow-through that makes alignment last.